webinar on role of afatinib in managing egfr mut ve patients and sequencing of lung tkis
Published 3 years ago • 88 plays • Length 42:56Download video MP4
Download video MP3
Similar videos
-
42:53
live webinar on role of afatinib in managing egfr mut ve patients and sequencing of lung tkis
-
5:47
egfr tkis for upfront treatment of nsclc
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
1:42
dr. bazhenova on sequential use of immunotherapy and egfr tkis in lung cancer
-
9:27
post-hoc analysis of sequential afatinib and osimertinib in nsclc patients
-
1:03:17
egfr positive webinar
-
3:16
impact of new tkis on nsclc treatment planning
-
3:07
efficacy and safety of afatinib vs erlotinib and gefitinib in egfr nsclc
-
2:49
the role of afatinib in patients with egfr nsclc
-
1:25
dr. bunn discusses afatinib in lung cancer
-
1:43:22
a webinar on molecular biomarker identification for right treatment decision in nsclc
-
43:43
webinar: going beyond egfr: evaluating technologies for molecular genetic testing in nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
1:59
oncology webinars success path - international association of oncology
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
1:04:40
moasc lung cancer webinar series - february 2023
-
1:31:58
a webinar past, present and future of lung cancer management
-
6:41
relay: erlotinib with ramucirumab for egfr nsclc
-
44:21
live webinar on advanced ovarian cancer prolonging survival in the present decade